As of March 23, 2026, Biomarin Pharmaceutical's top three insider holders are Jean Jacques Bienaime (Director, 473.79K shares), Henry J Fuchs (President, Worldwide Rd, 185.07K shares), Alexander Hardy (Chief Executive Officer, 159.39K shares).
| Holder | Position | Shares (Direct) | Shares (Indirect) | Report Date |
|---|---|---|---|---|
| Jean Jacques Bienaime | 473,792 | 0 | 21 May, 2024 | |
| Alexander Hardy | Chief Executive Officer | 214,635 | 0 | 19 Mar, 2026 |
| Henry J Fuchs | President, Worldwide Rd | 185,074 | 0 | 17 Sep, 2024 |
| Richard A Meier | 127,426 | 0 | 22 May, 2025 | |
| Brian Mueller | Evp, Chief Financial Officer | 123,314 | 0 | 19 Mar, 2026 |
| Elaine J Heron | 97,720 | 0 | 04 Jun, 2024 | |
| Charles Greg Guyer | Evp, Chief Technical Officer | 84,140 | 0 | 19 Mar, 2026 |
| George Eric Davis | Evp, Chief Legal Officer | 78,560 | 0 | 19 Mar, 2026 |
| Gregory R Friberg | Evp, Chief Rd Officer | 55,099 | 0 | 18 Mar, 2026 |
| David E I Pyott | 49,750 | 0 | 23 May, 2024 | |
| Cristin Hubbard | Evp, Chief Commercial Officer | 44,790 | 0 | 18 Mar, 2026 |
| Robert J. Hombach | 41,870 | 0 | 22 May, 2025 | |
| Willard H Dere | 38,950 | 0 | 22 May, 2025 | |
| V Bryan Lawlis | 33,140 | 0 | 24 May, 2023 | |
| Dennis Slamon | 31,299 | 0 | 20 Mar, 2024 | |
| Maykin Ho | 28,010 | 0 | 22 May, 2025 | |
| Rashmi Virendra Ramchandani | Vp, Chief Accounting Officer | 25,610 | 0 | 22 Jan, 2026 |
| Erin Burkhart | Gvp, Chief Accounting Officer | 14,173 | 0 | 20 May, 2025 |
| Barbara W. Bodem | 13,555 | 0 | 22 May, 2025 | |
| Athena Countouriotis | 13,550 | 0 | 22 May, 2025 | |
| Mark J Enyedy | 13,550 | 0 | 22 May, 2025 | |
| Timothy P Walbert | 9,780 | 0 | 22 May, 2025 | |
| Ian T Clark | 7,000 | 0 | 05 Aug, 2025 | |
| Jean Jacques Bienaime | Chief Executive Officer | 0 | 100 | 14 Feb, 2023 |
* Please note that the shares above only reflect shares from the fund portfolio and the institutional portfolio. Shares from the personal portfolio are excluded from this Institutional Ownership Page. See these insiders' latest transactions here on Insider Page.
| Transaction Date | Insider Name | Security Class | Transaction Type | Shares Traded | Price | Shares Remaining | Ownership | Code |
|---|---|---|---|---|---|---|---|---|
| 17 Mar, 2026 | Brian Mueller | Common Stock | D | 2,117 | $56.05 | 123,314 | D | F |
| 17 Mar, 2026 | Charles Greg Guyer | Common Stock | D | 1,693 | $56.05 | 84,140 | D | F |
| 17 Mar, 2026 | Alexander Hardy | Common Stock | D | 4,252 | $56.05 | 214,635 | D | F |
| 18 Mar, 2026 | George Eric Davis | Common Stock | D | 1,273 | $56.05 | 78,560 | D | F |
| 16 Mar, 2026 | Cristin Hubbard | Common Stock | A | 15,410 | $0.00 | 46,035 | D | A |
| 16 Mar, 2026 | Gregory R Friberg | Common Stock | A | 19,150 | $0.00 | 56,728 | D | A |
| 17 Mar, 2026 | Cristin Hubbard | Common Stock | D | 1,245 | $56.05 | 44,790 | D | F |
| 17 Mar, 2026 | Gregory R Friberg | Common Stock | D | 1,629 | $56.05 | 55,099 | D | F |
| 16 Mar, 2026 | Gregory R Friberg | Stock Option (Right to Buy Common Stock) | A | 45,600 | $0.00 | 45,600 | D | A |
| 16 Mar, 2026 | Cristin Hubbard | Stock Option (Right to Buy Common Stock) | A | 36,680 | $0.00 | 36,680 | D | A |
| 13 Mar, 2026 | Alexander Hardy | Common Stock | D | 2,941 | $58.51 | 156,447 | D | F |
| 13 Mar, 2026 | Brian Mueller | Common Stock | D | 9,945 | $58.51 | 106,691 | D | F |
| 16 Mar, 2026 | George Eric Davis | Common Stock | D | 7,177 | $58.51 | 65,263 | D | F |
| 13 Mar, 2026 | Charles Greg Guyer | Common Stock | D | 9,109 | $58.51 | 70,843 | D | F |
| 16 Mar, 2026 | Alexander Hardy | Common Stock | A | 62,440 | $0.00 | 218,887 | D | A |
| 16 Mar, 2026 | Charles Greg Guyer | Common Stock | A | 14,990 | $0.00 | 85,833 | D | A |
| 16 Mar, 2026 | Brian Mueller | Common Stock | A | 18,740 | $0.00 | 125,431 | D | A |
| 16 Mar, 2026 | George Eric Davis | Common Stock | A | 14,570 | $0.00 | 79,833 | D | A |
| 16 Mar, 2026 | Brian Mueller | Stock Option (Right to Buy Common Stock) | A | 44,600 | $0.00 | 44,600 | D | A |
| 16 Mar, 2026 | Alexander Hardy | Stock Option (Right to Buy Common Stock) | A | 89,200 | $0.00 | 89,200 | D | A |